Marine drugs: Implication and future studies

International Journal of Pharmacology

Volumn 7, Issue 1, 2011, Pages 22-30

  Vignesh, S ^a   Raja, A ^b   Arthur James, R ^a  

^a BHARATHIDASAN UNIVERSITY   (India)

^b JAMAL MOHAMED COLLEGE   (India)

Author keywords

Antibiotics; Anticancer; Antimicrobial; Drugs; Marinemicrobes

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; CYTARABINE; MARINE NATURAL PRODUCT; NATURAL PRODUCT; PENICILLIN G; THILO; UNCLASSIFIED DRUG; VIDARABIN; VIDARABINE;

ANTIBIOTIC RESISTANCE; ARTICLE; ASSAY; BACTERIAL ARTIFICIAL CHROMOSOME; DRUG SCREENING; DRUG STRUCTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MARINE BACTERIUM; MARINE FUNGUS; MARINE MICROORGANISM; MARINE SPECIES; METABOLIC ENGINEERING; METABOLITE; MICROORGANISM; MOLECULAR CLONING; MULTIDRUG RESISTANCE; NONHUMAN; PSEUDOMONAS INFECTION; RECOMBINANT DNA TECHNOLOGY; STAPHYLOCOCCUS AUREUS; VIRAL RESPIRATORY TRACT INFECTION;

EID: 78649378628     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2011.22.30     Document Type: Article

References (40)

1. Ahn, K.S., G. Sethi, T.H. Chao, S.T. Neuteboom and M.M. Chaturvedi et al, 2007. Salinosporamide A (NPI-0052) potentiates apoptosis, suppresses osteoclastogenesis and inhibits invasion through down-modulation of NF-kB regulated gene products. Blood, 10: 2286-2295.
2. Balaban, N. and G. Dell'Acqua, 2005. Barriers on the road to new antibiotics. Scientist, 19: 42-43.
3. Berdy, J., 2005. Bioactive microbial metabolites, a personal view. J. Antibiot, 58: 1-26.
4. Bergmann, W. and R. Feeney, 1951. Contributions to the study of marine products. XXXII. The nucleosides of sponges. J. Org. Chem., 16: 981-987.
5. Bhadury, P. and P.C. Wright, 2004. Exploitation of marine algae: Biogenic compounds for potential antifouling applications. Planta, 219: 561-578.
6. Blunt, J.W., B.R. Copp, W.P. Hu, M.H.G. Munro, P.T. Northcotec and M.R. Prinsepd, 2007. Marine natural products. Nat. Prod. Rep., 24: 31-86.
7. Bourguet-Kondracki, M.L. and J.M. Kornprobst, 2005. Marine pharmacology: Potentialities in the treatment of infectious diseases, osteoporosis and alzheimer's disease. Adv. Biochem.Eng. Biotechnol., 97: 105-131.
8. Chandran, S.S., J. Yi, K.M. Draths, R. von Daeniken, W. Weber and J.W. Frost 2003. Phosphoenolpyruvate availability and the biosynthesis of shikimic acid. Biotechnol. Prog., 19: 808-814.
9. Christie, S.N., C. McCaughey, M. McBnde and P. V. Coyle, 1997. Herpes simplex type 1 and genital herpes in northern Ireland. Int. J. STD AIDS, 8: 68-69.
10. Colwell, R.R., 2002. Fulfilling the promise of biotechnology. Biotechnol. Adv., 20: 215-228.
11. Cragg, G.M. and DJ. Newman, 2001. Medicinals for the millennia: The historical record. Ann. N. Y. Acad. Sei., 953: 3-25.
12. Cragg, G.M., DJ. Newman and S.S. Yang, 2006. Natural product extracts of plant and marine origin having antileukemia potential. The NCI Experience. J. Nat. Prod., 69: 488-498.
13. De Vries, DJ. andP.M. Beart, 1995. Fishing for drugs from the sea: Status and strategies. Trends Pharmacol. Sei., 16: 275-279.
14. Faulkner, DJ., 2002. Marine natural products. Nat. Prod. Rep., 19: 1-49.
15. Feting, R.H., G.O. Buchanan, T.J. Mincer, CA. Kauffman, P.R. Jensen and W. Fenical, 2003. Salinosporamide A: A highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus Salinospora. Angew. Chem. Int. Ed. Engl., 42: 355-357.
16. Hale, K.J., M.G. Hummersone, S. Manaviazar and M. Frigerio, 2002. The chemistry and biology of the bryostatin antitumour macrolides. Nat. Prod. Rep., 19: 413-453.
17. Hancock, R.E.W., 2007. The end of an era. Nat. Rev. Drug Discov., 6: 28-28.
18. Hoskeri, H.J., V. Krishna and C. Amruthavalli, 2010. Effects of extracts from lichen Ramalina pacifica against clinically infectious bacteria. Researcher, 2: 81-85.
19. Isaka, M., C. Suyarnsestakorn, M. Tanticharoen, P. Kongsaeree and Y. Thebtaranonth, 2002. Aigialomycins A-E, new resorcylic macrolides from the marine mangrove fungus Aigialus parvus. J. Org. Chem., 67: 1561-1566.
20. Jung, W.S., S.K. Lee, J.S.J. Hong, S.R Park and S.J. Jeong et al., 2006. Heterologous expression of tylosin polyketide synthase and production of a hybrid bioactive macrolide in Streptomyces venezuelae. Applied Microbiol. Biotechnol., 72: 763-769.
21. Lederberg, J., 2000. Infectious history. Science, 288: 287-293.
22. Lee, S.Y., H.U. Kim, J.H. Park, J.M. Park and T.Y. Kim, 2009. Metabolic engineering microorganisms: General strategies and drug production. Drug Discovery Today, 14: 78-88.
23. Liu, Z., P.R. Jensen and W. Fenical, 2003. A cyclic carbonate and related polyketides from a marine derived fungus of the genus Phoma. Phytochemistry, 64: 571-574.
24. Luesch, H., W.Y. Yoshida, R.E. Moore, V.J. Paul and T.H. Corbett, 2001. Total structure determination of apratoxin a, a potent novel cytotoxin from the marine cyanobacterium Lyngbya majuscula. J. Am. Chem. Soc, 123: 5418-5423.
25. Martin, V.J.J., D.J. Pitera, S.T. Withers, J.D. Newman and J.D. Keasling, 2003. Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nat. Biotech., 21: 796-802.
26. Minami, H., J.S. Kim, N. Ikezawa, T. Takemura, T. Katayama, H. Kumagai and F. Sato, 2008. Microbial production of plant benzylisoquinoline alkaloids. Proc. Natl. Acad. Sei. USA., 105: 7393-7398.
27. Moreira, D., F. Rodriguez-Valera and P. Lopez-Garcia, 2004. Analysis of a genome fragment of a deepsea uncultivated Group II euryarchaeote containing 16S rDNA, a spectinomycin-like Operon and several energy metabolism genes. Environ. Microbiol., 6: 959-969.
28. Morse, S.S., 1997. The public health threat of emerging viral disease. J.Nutr., 127: 951S-957S.
29. Okazaki, T., T. Kitahara and Y. Okami, 1975. Studies on marine microorganisms. IV. A new antibiotic SS-228 Y produced by Chainia isolated from shallow sea mud. J. Antibiot, 28: 176-84.
30. Patrzykat, A. and S.E. Douglas, 2003. Gone gene fishing: How to catch novel marine antimicrobials. Trends Biotechnol, 21: 362-369.
31. Raja, A., P. Prabakaran and P. Gajalakshmi, 2010. Isolation and screening of antibiotic producing psychrophilic actinomycetes and its nature from rothang hill soil against viridans Streptococcus sp. Res. J. Microbiol., 5: 44-49.
32. Rawat, D.S., M.C. Joshi, P. Joshi and H. Atheaya, 2006. Marine peptides and related compounds in clinical trial. AntiCancer Agents Med. Chem., 6: 33-40.
33. Rowley, D.C., S. Kelly, C.A. Kauffman, P.R. Jensen and W. Fenical, 2003. Halovirs A-E, new antiviral agents from a marinederived fungus of the genus Scytalidium. Bioorg. Med. Chem., 11: 4263-4274.
34. Schmid, I., I. Sattler, S. Grabley and R. Thiencke, 1999. Natural products in high throughput screening: Automated high-quality sample preparation. J. Biomol. Screen, 4: 15-25
35. Schweder, T., U. Lindequist and M. Lalk, 2005. Screening for new metabolites from marine microorganisms. Marine Biotechnol, 96: 1-48.
36. Shizuya, H., B. Birren, U.J. Kim, V. Mancmo, T. Slepak, Y. Tachiiri and M. Simon, 1992. Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector. Proc. Natl. Acad. Sei. USA., 89: 8794-8797.
37. Sudek, S., N.B. Lopanik, L.E. Waggoner, M. Hildebrand and C. Anderson et al., 2007. Identification of the putative bryostatin polyketide synthase gene clusters from Candidatus endobugula sertula, the uncultivated microbial symbiont of the marine byrozoan Bugula neritina. J. Nat. Prod., 70: 67-74.
38. Thakur, N.L., R. Jain, F. Natalio, B. Hamer, AN. Thakur and W.E.G. Muller, 2008. Marine molecular biology: An emerging field of biological sciences. Biotechnol. Adv., 26: 233-245.
39. Tsuda, M., T. Mugishima, K. Komatsu, T. Sone, M. Tanaka, Y. Mikami and J. Kobayashi, 2003. Modiolides A and B, two new 10-membered macrolides from a marine derived fungus. J. Nat. Prod., 66: 412-415.
40. Tziveleka, L.A., C. Vagias and V. Roussis, 2003. Natural products with anti-HIV activity from marine organisms. Curr. Top Med. Chem., 3: 1512-1535.